+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06759142

Study of Adults Diagnosed with Autosomal Dominant Polycystic Kidney Disease ADPKD Including Those on Tolvaptan or Octreotide Therapy

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-06

180

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are collecting clinical and genetic data from patients diagnosed with Autosomal Dominant Polycystic Kidney Disease ADPKD, focusing especially on those receiving specific treatments such as Tolvaptan or Octreotide. The study aims to analyze and compare clinical, laboratory, and imaging outcomes to better understand disease progression and treatment effects, particularly related to kidney function and cyst development. This observational research is conducted at the Integrated Renal Genetic Diseases Outpatient Clinic of the SantOrsola-Malpighi Polyclinic under the direction of Prof. La Manna. Participants will have their personal and family medical histories taken, and data will be gathered and updated through outpatient visits over time. The study pays close attention to the relationship between genetic variants and clinical outcomes, tracking kidney function markers like creatinine, eGFR, proteinuria, and urinary osmolarity. Imaging will be used to monitor changes in kidney cyst size and number, comparing patients on specific therapies versus those not receiving these treatments. Secondary objectives include monitoring cardiovascular health, urologic complications, liver involvement, and side effects related to the specific therapies, such as liver damage or symptoms from water loss or gastrointestinal issues. During the study, patients will undergo regular evaluations including clinical exams, laboratory tests, and imaging to assess kidney disease progression and treatment impact. Researchers will continuously update the database with these findings, focusing on kidney function decline and cyst growth as primary outcomes. Additional monitoring of blood pressure, heart and brain vessel conditions, urinary tract issues, and liver cysts will provide a comprehensive picture of disease effects. The study plans to follow participants for up to five years to build a detailed and ongoing data resource.

CONDITIONS

Brief Title

Analysis of Patients With Autosomal Dominant Polycystic Kidney

Research Team

G

Gaetano La Manna, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here